Today: 30 May 2026
Synopsys Stock Price Slides 5% Friday as Tech Rout Erases Elliott Boost
28 March 2026
1 min read

Synopsys Stock Price Slides 5% Friday as Tech Rout Erases Elliott Boost

NEW YORK, March 28, 2026, 11:09 EDT

Synopsys finished Friday down 5.4% at $380.47, a sharper loss than Cadence Design Systems, which slipped 3.1%. Investors broadly exited growth and software stocks as Wall Street pulled back.

The earlier pop from Elliott Investment Management’s multibillion-dollar stake didn’t last. Synopsys finished roughly 12% under Monday’s $432.48 close—a sharp swing that underscores just how quickly the mood has shifted for high-multiple chip software names.

It was a tough session for the broader market. The Nasdaq slid 2.15% Friday. S&P 500’s software and services index? Back at lows not seen since Nov. 6, 2023. “The overall tone has turned very negative,” said Ken Polcari, chief market strategist at SlateStone Wealth.

Synopsys provides EDA software, shorthand for electronic design automation, which engineers rely on to design and test chips ahead of fabrication. Its main rivals: Cadence and Siemens. Demand here tracks investment in AI and high-performance computing hardware.

The headline-grabbing AI narrative only tells part of the story. Back in February, Synopsys put out a second-quarter revenue forecast between $2.23 billion and $2.28 billion—topping consensus, but management flagged China export curbs and softer demand at a key foundry as trouble spots. “Excluding Ansys, China revenue declined slightly year-over-year, consistent with our outlook,” CFO Shelagh Glaser said. Reuters

Chief Executive Sassine Ghazi earlier this month introduced a set of new tools designed to tackle the increasing complexity of AI chips—marking the first major product launch since the $35 billion Ansys deal. According to Ghazi, engineers “still often work in a siloed way,” a practice he says drives up costs and hampers performance. Reuters

Elliott piled on last week, taking a multibillion-dollar stake in Synopsys and pressing the company to boost both sales and margins, a person familiar with the situation said. Synopsys responded by saying its board and management “regularly engage with our shareholders” and appreciate their feedback. Reuters

Here’s the near-term headache: If oil prices stick at these levels and yields keep climbing, investors may unload more of those expensive software stocks. According to JPMorgan, every persistent 10% jump in oil could trim 15 to 20 basis points off GDP. The bank also warned that if oil hovers around $110 a barrel through the end of 2026, consensus earnings forecasts might get cut by 2% to 5%.

The March U.S. jobs data lands next week, and the Iran conflict continues to produce new developments, with the Nasdaq and Dow both sitting in correction territory. Jim Baird, chief investment officer at Plante Moran Financial Advisors, said a breakthrough with Iran could help calm investors, but a prolonged standoff would likely weigh on sentiment.

Next up for Synopsys: can AI momentum, the Ansys deal, and Elliott’s push offset headwinds from China, acquisition debt, and a market that’s trimmed what it will shell out for growth stocks lately? As of Friday’s close, investors aren’t convinced.

Stock Market Today

  • QQQI ETF's 13.8% Yield Masks Return of Capital Risks
    May 30, 2026, 10:12 AM EDT. The NEOS Nasdaq-100 High Income ETF (QQQI) offers a 13.8% monthly yield by selling call options on Nasdaq-100 stocks like NVIDIA and Apple. This options premium funds distributions, which are partly treated as return of capital rather than traditional dividends, lowering investors' cost basis and posing hidden risks. Over the past year, QQQI surged 29%, trailing the Invesco QQQ Trust's 37%, reflecting the trade-off of capped upside in rallies. Compared to JPMorgan's JEPQ and Global X's QYLD, QQQI strikes a balance with moderate volatility and income generation. Investors should understand that QQQI's yield is a distribution rate supported by options strategies, not by earnings or cash flow, with potential impacts on total returns and net asset value.

Latest articles

Datadog Stock Just Jumped 9.8%; The Next Test Comes This Week

Datadog Stock Just Jumped 9.8%; The Next Test Comes This Week

30 May 2026
Datadog shares jumped 9.8% to $247.35 on Friday after RBC Capital raised its price target to $250. The stock rose 11.3% over the week, outpacing gains in the broader tech sector. Datadog reported first-quarter revenue of $1.006 billion, up 32% year-over-year, and announced FedRAMP High certification for its government cloud offering.
Workday up 12% as investors look again at AI risk

Workday up 12% as investors look again at AI risk

30 May 2026
Workday shares jumped 12.45% to $146.19 Friday after beating first-quarter earnings forecasts and raising its margin outlook. The stock ended the week up 14%. Workday reported Q1 revenue of $2.54 billion, with subscription revenue up 14.3%. Investors expect more AI product details at next week’s developer conference.
Clorox Stock Drops After CEO Exit Plan: What Investors Need to Watch Next

Clorox Stock Drops After CEO Exit Plan: What Investors Need to Watch Next

30 May 2026
Clorox shares fell 6.4% to $90.02 Friday after CEO Linda Rendle said she would step down for health reasons, intensifying concerns over weak sales and profit outlook. Trading volume jumped to 4.6 million shares. The stock underperformed peers as the S&P 500 and Dow rose. Rendle will remain in her roles until a successor is named.
Amazon Stock (AMZN) Drops Toward $200 as Nasdaq Correction Revives AI Spending Fears
Previous Story

Amazon Stock (AMZN) Drops Toward $200 as Nasdaq Correction Revives AI Spending Fears

Vertex Pharmaceuticals Stock Falls 4.6% After FDA Label Warning Hits Alyftrek, Trikafta
Next Story

Vertex Pharmaceuticals Stock Falls 4.6% After FDA Label Warning Hits Alyftrek, Trikafta

Go toTop